Avalun SAS of Grenoble at MEDICA 2017 in Düsseldorf -- COMPAMED Trade Fair
Manufacturers

Avalun SAS

7 Parvis Louis Néel, 38000 Grenoble
France

Telephone +33 603 880447
cecile.gross@avalun.com

This company is co-exhibitor of
Business France

Hall map

MEDICA 2017 hall map (Hall 3): stand G80

Fairground map

MEDICA 2017 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.14  Rapid tests - clinical chemistry

Rapid tests - clinical chemistry

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.14  Rapid tests - clinical chemistry
  • 03.01.14.01  Point of care - testing systems

Point of care - testing systems

Our products

Product category: Rapid tests - clinical chemistry, Point of care - testing systems

LabPad®

Ever since it was founded, Avalun has focused its efforts on developing LabPad®, a connected Handy Lab designed to address the needs for multiparametric near-patient testing.

Based on a unique and patented lensless optical technology, this smart system consists of a fully automated "miniaturized microscope" and a range of Tsmart® single-use microcuvettes integrating innovative microfluidics. Once inserted into the device, the Tsmart® faces a CMOS sensor and is lit by different light sources. When capillary blood dissolves the Tsmart®’s embedded reagent, test-specific biological phenomena are observed in real time, and a dedicated image-processing algorithm produces the result.

LabPad® is a generic platform enabling measurements with the same device in the fields of:

Hemostasis, in particular with the PT/INR test (by blood dynamics imaging);
Biochemistry, in particular for blood glucose (by colorimetry);
Immunohematology, in particular for direct blood typing (by particle agglutination imaging);
Cytology (by microscopic image reconstruction);
Immunology, for measuring different biomarkers (by reading out immunochromatographic tests).
Building on these unique features, Avalun’s objective is to provide patients and healthcare professionals "here and now" with the reliable biological parameters they need. While developing LabPad®, special attention was paid to its functionalities and its ergonomics so that smooth integration into care processes can be obtained. Two U&A studies were carried out prior to and during the development phase. The first, which included 50 patients and 130 healthcare professionals, was conducted in 2013 by Pierre Mendès-France University (Grenoble, France); the second, more specifically dedicated to the environment of the "connected patient", was conducted by Sherbrooke University (Sherbrooke, Canada).
 
The first Tsmart® to be marketed makes it possible to measure coagulation time (PT/INR test). Additional tests are currently being designed, either by Avalun itself or by its partners. To accelerate the availability of new tests, Avalun intends to promote cooperation with in-vitro diagnostics players wishing to benefit from its technology.

More Less

About us

Company details

As a young innovative company, our ambition is to address one of the main challenges for tomorrow’s medicine: to make available, here and now, the biological parameters that patients and healthcare professionals need. Because we put patients first, we focus all our energy on developing our next-generation LabPad® POC testing device and its associated Tsmart® range of microcuvettes.

Avalun is a spin-off company from the top French research center CEA/Leti. Our project started off there after a meeting with Vincent Poher, a specialist in photonics with a PhD from the Imperial College of London, and Patrick Pouteau, a researcher involved for more than 15 years in the development of health-related microsystems. Understanding the amazing potential of patented lensless imaging technology to satisfy unmet needs for point-of-care patient testing, they together designed an initial prototype with the objective of helping to improve our healthcare systems. In June 2013, the project was awarded by the French Ministry of Higher Education and Research, and Avalun, from the Greek "ἀνάλυσις" or "analysis", was founded in November of the same year.

Today, our multidisciplinary team consists of 20 dedicated individuals providing their unique expertise and sharing the same passion for innovation and health care. Driven by our quality system, our values are excellence, commitment, and responsibility.

More Less